Corvus Pharmaceuticals Inc (NASDAQ:CRVS)

4.10
Delayed Data
As of May 17
 -0.08 / -1.91%
Today’s Change
3.22
Today|||52-Week Range
13.91
+11.72%
Year-to-Date

Today’s Trading

Previous close4.18
Today’s open4.11
Day’s range4.00 - 4.18
Volume31,486
Average volume (3 months)85,625
Market cap$120.2M
Data as of 3:59pm ET, 05/17/2019

Growth & Valuation

Earnings growth (last year)+37.27%
Earnings growth (this year)-2.73%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.09

Competitors

 Today’s
change
Today’s
% change
MDWDMediwound Ltd-0.02-0.45%
DRRXDURECT Corp+0.00+0.36%
FBIOFortress Biotech Inc-0.03-1.55%
TRVNTrevena Inc+0.01+0.75%
Data as of 4:00pm ET, 05/17/2019

Financials

Next reporting dateAugust 5, 2019
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$0.00
Annual profit (last year)-$46.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Richard A. Miller
CFO &
Principal Accounting Officer
Leiv Lea
Corporate headquarters
Burlingame, California

Forecasts